Konan, Japan

Seiichi Niwa

This inventor holds 1 USPTO granted patent. Top assignee: Zeria Pharmaceutical Co., Ltd.. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seiichi Niwa. Retrieved from https://idiyas.com/inventor/seiichi-niwa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seiichi Niwa: Innovator in Pharmaceutical Chemistry

Introduction

Seiichi Niwa is a notable inventor based in Konan, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on quaternary ammonium salts.

Latest Patents

Seiichi Niwa holds 1 patent for his invention titled "Quaternary ammonium salts and use thereof as medicine." This patent highlights his expertise in developing compounds that have potential applications in medical treatments.

Career Highlights

Niwa is currently employed at Zeria Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work at Zeria has positioned him as a key player in the pharmaceutical industry, contributing to the development of new medicinal products.

Collaborations

Throughout his career, Seiichi Niwa has collaborated with esteemed colleagues such as Masao Seiki and Osamu Kitagawa. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Seiichi Niwa's contributions to pharmaceutical chemistry, particularly through his patented work, underscore his role as an influential inventor in the industry. His ongoing efforts at Zeria Pharmaceutical Co., Ltd. continue to shape the future of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…